These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2175763)

  • 1. [Serum levels of beta-seminoprotein (beta-Sm) in patients with breast cancer].
    Fujimasa A; Fukushima T; Yuge S; Tanaka M; Koga T; Nishimura Y; Takeda J; Kakegawa T; Fukushima I; Yuge S
    Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2511-8. PubMed ID: 2175763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of serum gamma-seminoprotein in patients with prostatic cancer].
    Ishihara Y; Hiromoto Y; Higaki Y; Imamura K
    Hinyokika Kiyo; 1989 Mar; 35(3):409-13. PubMed ID: 2660507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma].
    Sugimura Y; Sakurai M; Hioki T; Hayashi N; Yamakawa K; Tajima K; Tochigi H; Kawamura J
    Hinyokika Kiyo; 1988 Dec; 34(12):2129-34. PubMed ID: 2467541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
    Watanabe M; Kitamura Y; Komatsubara S; Sakata Y
    Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies of gamma-seminoprotein in prostatic disease. I. Clinical evaluation of serum gamma-seminoprotein].
    Hasegawa S; Nakashima J; Nakashima Y; Nakamura S; Kimura S
    Hinyokika Kiyo; 1987 Dec; 33(12):2055-8. PubMed ID: 3329453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in the urine. First report: the measurement of PAP, gamma-Sm and PA in the urine of patients with prostatic diseases].
    Uchijima Y; Yoshida K; Saitoh H
    Hinyokika Kiyo; 1991 Oct; 37(10):1255-60. PubMed ID: 1721770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
    Akimoto S; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of serum riboflavin carrier protein in breast cancer.
    Rao PN; Levine E; Myers MO; Prakash V; Watson J; Stolier A; Kopicko JJ; Kissinger P; Raj SG; Raj MH
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):985-90. PubMed ID: 10566553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum gamma-seminoprotein determination in prostatic cancer.
    Shimazaki J; Akimoto S; Akakura K; Yoshiki T; Yoshida O; Okada K; Matsuoka K; Noda S; Eto K
    Hinyokika Kiyo; 1991 Apr; 37(4):341-7. PubMed ID: 1716404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
    Sakai N; Ogawa T; Ishibashi Y; Fukuoka H; Sakanishi S
    Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of tumor markers in prostatic cancer].
    Ishihara Y; Fukagai T; Ohta K; Hiromoto Y; Hiramori M; Torii T; Higaki Y; Imamura K
    Hinyokika Kiyo; 1990 Apr; 36(4):425-31. PubMed ID: 1696063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
    Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J
    Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
    Yoshiki T; Okada K; Oishi K; Yoshida O
    Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein].
    Shinoda I
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2627-39. PubMed ID: 1703555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies of gamma-seminoprotein in prostatic disease. II. Immunohistochemical study of gamma-seminoprotein].
    Nakashima J; Hasegawa S; Nakashima Y; Nakamura S; Kimura S; Tachibana M; Deguchi N; Tazaki H
    Hinyokika Kiyo; 1987 Dec; 33(12):2059-63. PubMed ID: 3329454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
    Arai Y; Yoshki T; Okada K; Yoshida O; Yamamoto N; Sakatoku J; Sugimura Y; Kawamura J
    Hinyokika Kiyo; 1989 Sep; 35(9):1519-28. PubMed ID: 2479237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pregnancy protein-1 in the serum of patients with diseases of the breast].
    Strache RR; Briese V; Szabo DG; Than GN; Kunze M; Richter D
    Zentralbl Gynakol; 1987; 109(5):274-9. PubMed ID: 3035827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection method and breast carcinoma histology.
    Newcomer LM; Newcomb PA; Trentham-Dietz A; Storer BE; Yasui Y; Daling JR; Potter JD
    Cancer; 2002 Aug; 95(3):470-7. PubMed ID: 12209738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)].
    Tsukamoto T; Kumamoto Y; Yamazaki K; Umehara T; Miyao N; Ohmura K; Iwazawa M
    Hinyokika Kiyo; 1988 Jun; 34(6):987-95. PubMed ID: 2464917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
    Samy N; Ragab HM; El Maksoud NA; Shaalan M
    Cancer Biomark; 2010; 6(2):63-72. PubMed ID: 20571232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.